• Users Online: 403
  • Print this page
  • Email this page
Year : 2022  |  Volume : 19  |  Issue : 1  |  Page : 24-26

Supply chain and logistics for COVID-19 vaccines: Challenges and opportunities

1 Department of Mechanical Engineering, Jamia Millia Islamia, New Delhi, India
2 Department of Biotechnology, Amity University, Noida, India
3 Department of Conservative Dentistry and Endodontics, Jamia Millia Islamia, New Delhi, India

Correspondence Address:
Shanay Rab
Department of Mechanical Engineering, Jamia Millia Islamia, New Delhi, 110025
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/am.am_127_21

Rights and Permissions

According to the history of vaccine development, no vaccine for infectious disease has ever been developed in a shorter time than COVID-19. With the enabling scientific efforts and governments support, few vaccines for the COVID-19 have been developed across the globe. Using the keywords COVID-19 or coronavirus and vaccine supply chain management, and review of the literature are conducted on the databases of PubMed, Scopus, and Google Scholar. Study, collected the most up-to-date information on the COVID-19 vaccine supply chain, and then assessed it to find potential challenges and opportunities. Our prior understanding of the structure and function of the coronavirus family has also contributed to the quick development of several vaccination technologies. However, there is still a long way to go in terms of actually getting the vaccinations to people, as well as others that are on the way. In 2021 and beyond, the complicated logistics of controlling the vaccine cold chain, combined with limited government funding to assist distribution, will make mass immunization difficult. We have identified various challenges and opportunities related to the supply chain and logistics for COVID-19 vaccines. The solution to these challenges would play a crucial role to enhance the health quality infrastructure across the world. The present study discusses the various aspects of the COVID-19 vaccine supply chain and logistics that make its biggest challenges. The scale and short time required for global vaccination will teach lessons not only to researchers and manufacturers but also to supply chain managers. Scientists, researchers, and diverse sectors have all also benefited from the influx of opportunities.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal